Challenges to production of antibodies in bacteria and yeast

Journal of Bioscience and Bioengineering

Volumn 120, Issue 5, 2015, Pages 483-490

  Lee, Yong Jae ^a   Jeong, Ki Jun ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Antibody; Antibody fragments; Escherichia coli; Yeast

Indexed keywords

BACTERIA; CELL ENGINEERING; COMMERCE; CULTIVATION; DIAGNOSIS; ESCHERICHIA COLI; GENETIC ENGINEERING; MAMMALS; YEAST;

ANTIBODY FRAGMENT; ANTIBODY THERAPEUTICS; LONG-TERM CULTIVATIONS; MAMMALIAN HOSTS; PHARMACEUTICAL DRUGS; SYSTEMS BIOTECHNOLOGY; THERAPEUTIC ANTIBODIES; VIRAL INFECTIONS;

ANTIBODIES;

IMMUNOGLOBULIN G; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; ANTIBODY;

ANTIBODY PRODUCTION; BACTERIAL METABOLISM; BACTERIUM; BIOENGINEERING; FUNGAL METABOLISM; REVIEW; YEAST; ANIMAL; BIOTECHNOLOGY; CHEMISTRY; GENETIC ENGINEERING; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PROCEDURES;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; BACTERIA; BIOTECHNOLOGY; GENETIC ENGINEERING; HUMANS; YEASTS;

EID: 84943355308     PISSN: 13891723     EISSN: 13474421     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2015.03.009     Document Type: Review

References (87)

1. Buelens K., Hassanzadeh-Ghassabeh G., Muyldermans S., Gils A., Declerck P.J. Generation and characterization of inhibitory nanobodies towards thrombin activatable fibrinolysis inhibitor. J. Thromb. Haemost. 2010, 8:1302-1312.
2. Elvin J.G., Couston R.G., van der Walle C.F. Therapeutic antibodies: market considerations, disease targets and bioprocessing. Int. J. Pharm. 2013, 440:83-98.
3. Rodrigues M.E., Costa A.R., Henriques M., Azeredo J., Oliveira R. Technological progresses in monoclonal antibody production systems. Biotechnol. Prog. 2010, 26:332-351.
4. Wurm F.M. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotechnol. 2004, 22:1393-1398.
5. Farid S.S. Process economics of industrial monoclonal antibody manufacture. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2007, 848:8-18.
6. Li J., Zhu Z. Research and development of next generation of antibody-based therapeutics. Acta Pharmacol. Sin. 2010, 31:1198-1207.
7. Frenzel A., Hust M., Schirrmann T. Expression of recombinant antibodies. Front. Immunol. 2013, 4:217.
8. Skerra A., Pluckthun A. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 1988, 240:1038-1041.
9. Bird R.E., Hardman K.D., Jacobson J.W., Johnson S., Kaufman B.M., Lee S.M., Lee T., Pope S.H., Riordan G.S., Whitlow M. Single-chain antigen-binding proteins. Science 1988, 242:423-426.
10. Better M., Chang C.P., Robinson R.R., Horwitz A.H. Escherichia coli secretion of an active chimeric antibody fragment. Science 1988, 240:1041-1043.
11. Bothmann H., Pluckthun A. The periplasmic Escherichia coli peptidylprolyl cis,trans-isomerase FkpA. I. Increased functional expression of antibody fragments with and without cis-prolines. J. Biol. Chem. 2000, 275:17100-17105.
12. Sonoda H., Kumada Y., Katsuda T., Yamaji H. Effects of cytoplasmic and periplasmic chaperones on secretory production of single-chain Fv antibody in Escherichia coli. J. Biosci. Bioeng. 2011, 111:465-470.
13. Wang R., Xiang S., Feng Y., Srinivas S., Zhang Y., Lin M., Wang S. Engineering production of functional scFv antibody in E. coli by co-expressing the molecule chaperone Skp. Front. Cell Infect. Microbiol. 2013, 3:72.
14. Ellis M., Humphreys D.P. Bacterial host strain expressing recombinant DsbC, WO 2011086141 A1 2013.
15. Nannenga B.L., Baneyx F. Reprogramming chaperone pathways to improve membrane protein expression in Escherichia coli. Protein Sci. 2011, 20:1411-1420.
16. Lee Y.J., Jeong K.J. Enhanced production of antibody fragment via SRP pathway engineering in Escherichia coli. Biotechnol. Bioprocess Eng. 2013, 18:751-758.
17. Chen C., Snedecor B., Nishihara J.C., Joly J.C., McFarland N., Andersen D.C., Battersby J.E., Champion K.M. High-level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple-mutant (degP prc spr) host strain. Biotechnol. Bioeng. 2004, 85:463-474.
18. Sonoda H., Kumada Y., Katsuda T., Yamaji H. Functional expression of single-chain Fv antibody in the cytoplasm of Escherichia coli by thioredoxin fusion and co-expression of molecular chaperones. Protein Expr. Purif. 2010, 70:248-253.
19. Levy R., Weiss R., Chen G., Iverson B.L., Georgiou G. Production of correctly folded Fab antibody fragment in the cytoplasm of Escherichia coli trxB gor mutants via the coexpression of molecular chaperones. Protein Expr. Purif. 2001, 23:338-347.
20. Vaks L., Benhar I. Production of stabilized scFv antibody fragments in the E. coli bacterial cytoplasm. Methods Mol. Biol. 2014, 1060:171-184.
21. Zheng L., Baumann U., Reymond J.L. Production of a functional catalytic antibody ScFv-NusA fusion protein in bacterial cytoplasm. J. Biochem. 2003, 133:577-581.
22. Bach H., Mazor Y., Shaky S., Shoham-Lev A., Berdichevsky Y., Gutnick D.L., Benhar I. Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies. J. Mol. Biol. 2001, 312:79-93.
23. Park J.H., Kwon H.W., Jeong K.J. Development of a plasmid display system with an Oct-1 DNA-binding domain suitable for in vitro screening of engineered proteins. J. Biosci. Bioeng. 2013, 116:246-252.
24. Proba K., Worn A., Honegger A., Pluckthun A. Antibody scFv fragments without disulfide bonds made by molecular evolution. J. Mol. Biol. 1998, 275:245-253.
25. Worn A., Pluckthun A. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability. Biochemistry 1998, 37:13120-13127.
26. Martineau P., Jones P., Winter G. Expression of an antibody fragment at high levels in the bacterial cytoplasm. J. Mol. Biol. 1998, 280:117-127.
27. Seo M.J., Jeong K.J., Leysath C.E., Ellington A.D., Iverson B.L., Georgiou G. Engineering antibody fragments to fold in the absence of disulfide bonds. Protein Sci. 2009, 18:259-267.
28. Fernandez L.A., Sola I., Enjuanes L., de Lorenzo V. Specific secretion of active single-chain Fv antibodies into the supernatants of Escherichia coli cultures by use of the hemolysin system. Appl. Environ. Microbiol. 2000, 66:5024-5029.
29. Cheng C.M., Tzou S.C., Zhuang Y.H., Huang C.C., Kao C.H., Liao K.W., Cheng T.C., Chuang C.H., Hsieh Y.C., Tai M.H., Cheng T.L. Functional production of a soluble and secreted single-chain antibody by a bacterial secretion system. PLoS One 2014, 9:e97367.
30. Buss N.A., Henderson S.J., McFarlane M., Shenton J.M., de Haan L. Monoclonal antibody therapeutics: history and future. Curr. Opin. Pharmacol. 2012, 12:615-622.
31. Wacker M., Linton D., Hitchen P.G., Nita-Lazar M., Haslam S.M., North S.J., Panico M., Morris H.R., Dell A., Wren B.W., Aebi M. N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli. Science 2002, 298:1790-1793.
32. Valderrama-Rincon J.D., Fisher A.C., Merritt J.H., Fan Y.Y., Reading C.A., Chhiba K., Heiss C., Azadi P., Aebi M., DeLisa M.P. An engineered eukaryotic protein glycosylation pathway in Escherichia coli. Nat. Chem. Biol. 2012, 8:434-436.
33. Fisher A.C., Haitjema C.H., Guarino C., Celik E., Endicott C.E., Reading C.A., Merritt J.H., Ptak A.C., Zhang S., DeLisa M.P. Production of secretory and extracellular N-linked glycoproteins in Escherichia coli. Appl. Environ. Microbiol. 2011, 77:871-881.
34. Feldman M.F., Wacker M., Hernandez M., Hitchen P.G., Marolda C.L., Kowarik M., Morris H.R., Dell A., Valvano M.A., Aebi M. Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli. Proc. Natl. Acad. Sci. USA 2005, 102:3016-3021.
35. Sazinsky S.L., Ott R.G., Silver N.W., Tidor B., Ravetch J.V., Wittrup K.D. Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors. Proc. Natl. Acad. Sci. USA 2008, 105:20167-20172.
36. Jung S.T., Reddy S.T., Kang T.H., Borrok M.J., Sandlie I., Tucker P.W., Georgiou G. Aglycosylated IgG variants expressed in bacteria that selectively bind FcgammaRI potentiate tumor cell killing by monocyte-dendritic cells. Proc. Natl. Acad. Sci. USA 2010, 107:604-609.
37. Jung S.T., Kelton W., Kang T.H., Ng D.T., Andersen J.T., Sandlie I., Sarkar C.A., Georgiou G. Effective phagocytosis of low Her2 tumor cell lines with engineered, aglycosylated IgG displaying high FcgammaRIIa affinity and selectivity. ACS Chem. Biol. 2013, 8:368-375.
38. Ju M.S., Jung S.T. Aglycosylated full-length IgG antibodies: steps toward next-generation immunotherapeutics. Curr. Opin. Biotechnol. 2014, 30:128-139.
39. Jung S.T., Kang T.H., Kelton W., Georgiou G. Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy. Curr. Opin. Biotechnol. 2011, 22:858-867.
40. Simmons L.C., Reilly D., Klimowski L., Raju T.S., Meng G., Sims P., Hong K., Shields R.L., Damico L.A., Rancatore P., Yansura D.G. Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies. J. Immunol. Methods 2002, 263:133-147.
41. Reilly D.E., Yansura D.G. Production of monoclonal antibodies in E. coli, pp. 295-308. Current trends in monoclonal antibody development and manufacturing 2010, vol. 14. Springer: AAPS Press, New York.
42. Chan C.E., Lim A.P., Chan A.H., MacAry P.A., Hanson B.J. Optimized expression of full-length IgG1 antibody in a common E. coli strain. PLoS One 2010, 5:e10261.
43. Makino T., Skretas G., Kang T.H., Georgiou G. Comprehensive engineering of Escherichia coli for enhanced expression of IgG antibodies. Metab. Eng. 2011, 13:241-251.
44. Lee Y.J., Kim H.S., Ryu A.J., Jeong K.J. Enhanced production of full-length immunoglobulin G via the signal recognition particle (SRP)-dependent pathway in Escherichia coli. J. Biotechnol. 2013, 165:102-108.
45. Lee Y.J., Lee D.H., Jeong K.J. Enhanced production of human full-length immunoglobulin G1 in the periplasm of Escherichia coli. Appl. Microbiol. Biotechnol. 2014, 98:1237-1246.
46. Hakim R., Benhar I. "Inclonals": IgGs and IgG-enzyme fusion proteins produced in an E. coli expression-refolding system. MAbs 2009, 1:281-287.
47. Lv Y., Wu Z., Han S., Lin Y., Zheng S. Construction of recombinant Corynebacterium glutamicum for l-threonine production. Biotechnol. Bioproc. Eng. 2012, 17:16-21.
48. Yim S.S., An S.J., Choi J.W., Ryu A.J., Jeong K.J. High-level secretory production of recombinant single-chain variable fragment (scFv) in Corynebacterium glutamicum. Appl. Microbiol. Biotechnol. 2014, 98:273-284.
49. Matsuda Y., Itaya H., Kitahara Y., Theresia N.M., Kutukova E.A., Yomantas Y.A., Date M., Kikuchi Y., Wachi M. Double mutation of cell wall proteins CspB and PBP1a increases secretion of the antibody Fab fragment from Corynebacterium glutamicum. Microb. Cell Fact. 2014, 13:56.
50. Jordan E., Al-Halabi L., Schirrmann T., Hust M., Dubel S. Production of single chain Fab (scFab) fragments in Bacillus megaterium. Microb. Cell Fact. 2007, 6:38.
51. Jordan E., Hust M., Roth A., Biedendieck R., Schirrmann T., Jahn D., Dubel S. Production of recombinant antibody fragments in Bacillus megaterium. Microb. Cell Fact. 2007, 6:2.
52. Vary P.S. Prime time for Bacillus megaterium. Microbiol. 1994, 140(Pt 5):1001-1013.
53. Dammeyer T., Steinwand M., Kruger S.C., Dubel S., Hust M., Timmis K.N. Efficient production of soluble recombinant single chain Fv fragments by a Pseudomonas putida strain KT2440 cell factory. Microb. Cell Fact. 2011, 10:11.
54. Gasser B., Maurer M., Gach J., Kunert R., Mattanovich D. Engineering of Pichia pastoris for improved production of antibody fragments. Biotechnol. Bioeng. 2006, 94:353-361.
55. Gasser B., Mattanovich D. Antibody production with yeasts and filamentous fungi: on the road to large scale?. Biotechnol. Lett. 2007, 29:201-212.
56. Fleer R. Engineering yeast for high level expression. Curr. Opin. Biotechnol. 1992, 3:486-496.
57. Shusta E.V., Raines R.T., Pluckthun A., Wittrup K.D. Increasing the secretory capacity of Saccharomyces cerevisiae for production of single-chain antibody fragments. Nat. Biotechnol. 1998, 16:773-777.
58. Macauley-Patrick S., Fazenda M.L., McNeil B., Harvey L.M. Heterologous protein production using the Pichia pastoris expression system. Yeast 2005, 22:249-270.
59. Jeong K.J., Jang S.H., Velmurugan N. Recombinant antibodies: engineering and production in yeast and bacterial hosts. Biotechnol. J. 2011, 6:16-27.
60. Jeong G.M., Lee Y.J., Kim Y.S., Jeong K.J. High-level production of Fc-fused kringle domain in Pichia pastoris. J. Ind. Microbiol. Biotechnol. 2014, 41:989-996.
61. Ridder R., Schmitz R., Legay F., Gram H. Generation of rabbit monoclonal antibody fragments from a combinatorial phage display library and their production in the yeast Pichia pastoris. Biotechnology (NY) 1995, 13:255-260.
62. Ning D., Junjian X., Qing Z., Sheng X., Wenyin C., Guirong R., Xunzhang W. Production of recombinant humanized anti-HBsAg Fab fragment from Pichia pastoris by fermentation. J. Biochem. Mol. Biol. 2005, 38:294-299.
63. Burtet R.T., Santos-Silva M.A., Buss G.A., Moraes L.M., Maranhao A.Q., Brigido M.M. Production of a recombinant Fab in Pichia pastoris from a monocistronic expression vector. J. Biochem. 2007, 142:665-669.
64. Garcia-Ortega X., Ferrer P., Montesinos J.L., Valero F. Fed-batch operational strategies for recombinant Fab production with Pichia pastoris using the constitutive GAP promoter. Biochem. Eng. J. 2013, 79:172-181.
65. Rakestraw J.A., Sazinsky S.L., Piatesi A., Antipov E., Wittrup K.D. Directed evolution of a secretory leader for the improved expression of heterologous proteins and full-length antibodies in Saccharomyces cerevisiae. Biotechnol. Bioeng. 2009, 103:1192-1201.
66. Borth N., Mattanovich D., Kunert R., Katinger H. Effect of increased expression of protein disulfide isomerase and heavy chain binding protein on antibody secretion in a recombinant CHO cell line. Biotechnol. Prog. 2005, 21:106-111.
67. Damasceno L.M., Anderson K.A., Ritter G., Cregg J.M., Old L.J., Batt C.A. Cooverexpression of chaperones for enhanced secretion of a single-chain antibody fragment in Pichia pastoris. Appl. Microbiol. Biotechnol. 2007, 74:381-389.
68. Valkonen M., Penttila M., Saloheimo M. Effects of inactivation and constitutive expression of the unfolded protein response pathway on protein production in the yeast Saccharomyces cerevisiae. Appl. Environ. Microbiol. 2003, 69:2065-2072.
69. Swennen D., Paul M.F., Vernis L., Beckerich J.M., Fournier A., Gaillardin C. Secretion of active anti-Ras single-chain Fv antibody by the yeasts Yarrowia lipolytica and Kluyveromyces lactis. Microbiol. 2002, 148:41-50.
70. Horwitz A.H., Chang C.P., Better M., Hellstrom K.E., Robinson R.R. Secretion of functional antibody and Fab fragment from yeast cells. Proc. Natl. Acad. Sci. USA 1988, 85:8678-8682.
71. Hamilton S.R., Bobrowicz P., Bobrowicz B., Davidson R.C., Li H., Mitchell T., Nett J.H., Rausch S., Stadheim T.A., Wischnewski H., Wildt S., Gerngross T.U. Production of complex human glycoproteins in yeast. Science 2003, 301:1244-1246.
72. Hamilton S.R., Davidson R.C., Sethuraman N., Nett J.H., Jiang Y., Rios S., Bobrowicz P., Stadheim T.A., Li H., Choi B.K., other 8 authors Humanization of yeast to produce complex terminally sialylated glycoproteins. Science 2006, 313:1441-1443.
73. Li H., Sethuraman N., Stadheim T.A., Zha D., Prinz B., Ballew N., Bobrowicz P., Choi B.K., Cook W.J., Cukan M., other 13 authors Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nat. Biotechnol. 2006, 24:210-215.
74. Zhang N., Liu L., Dumitru C.D., Cummings N.R., Cukan M., Jiang Y., Li Y., Li F., Mitchell T., Mallem M.R., other 9 authors Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study. MAbs 2011, 3:289-298.
75. Barnard G.C., Kull A.R., Sharkey N.S., Shaikh S.S., Rittenhour A.M., Burnina I., Jiang Y., Li F., Lynaugh H., Mitchell T., other 9 authors High-throughput screening and selection of yeast cell lines expressing monoclonal antibodies. J. Ind. Microbiol. Biotechnol. 2010, 37:961-971.
76. Potgieter T.I., Cukan M., Drummond J.E., Houston-Cummings N.R., Jiang Y., Li F., Lynaugh H., Mallem M., McKelvey T.W., Mitchell T., other 5 authors Production of monoclonal antibodies by glycoengineered Pichia pastoris. J. Biotechnol. 2009, 139:318-325.
77. Potgieter T.I., Kersey S.D., Mallem M.R., Nylen A.C., d'Anjou M. Antibody expression kinetics in glycoengineered Pichia pastoris. Biotechnol. Bioeng. 2010, 106:918-927.
78. Ye J., Ly J., Watts K., Hsu A., Walker A., McLaughlin K., Berdichevsky M., Prinz B., Sean Kersey D., d'Anjou M., Pollard D., Potgieter T. Optimization of a glycoengineered Pichia pastoris cultivation process for commercial antibody production. Biotechnol. Prog. 2011, 27:1744-1750.
79. Kumada Y., Sakan Y., Kajihara H., Kihara M., Kikuchi Y., Yamaji H., Seong G.H., Katoh S. Efficient production of single-chain Fv antibody possessing rare codon linkers in fed-batch fermentation. J. Biosci. Bioeng. 2009, 107:73-77.
80. Carter P., Kelley R.F., Rodrigues M.L., Snedecor B., Covarrubias M., Velligan M.D., Wong W.L.T., Rowland A.M., Kotts C.E., Carver M.E., other 4 authors High level Escherichia coli expression and production of a bivalent humanized antibody fragment. Nat. Biotechnol. 1992, 10:163-167.
81. Inoue Y., Ohta T., Tada H., Iwasa S., Udaka S., Yamagata H. Efficient production of a functional mouse/human chimeric Fab' against human urokinase-type plasminogen activator by Bacillus brevis. Appl. Microbiol. Biotechnol. 1997, 48:487-492.
82. Eldin P., Pauza M.E., Hieda Y., Lin G., Murtaugh M.P., Pentel P.R., Pennell C.A. High-level secretion of two antibody single chain Fv fragments by Pichia pastoris. J. Immunol. Methods 1997, 201:67-75.
83. Gurkan C., Symeonides S.N., Ellar D.J. High-level production in Pichia pastoris of an anti-p185HER-2 single-chain antibody fragment using an alternative secretion expression vector. Biotechnol. Appl. Biochem. 2004, 39:115-122.
84. Khatri N.K., Gocke D., Trentmann O., Neubauer P., Hoffmann F. Single-chain antibody fragment production in Pichia pastoris: benefits of prolonged pre-induction glycerol feeding. Biotechnol. J. 2011, 6:452-462.
85. Yamawaki S., Matsumoto T., Ohnishi Y., Kumada Y., Shiomi N., Katsuda T., Lee E.K., Katoh S. Production of single-chain variable fragment antibody (scFv) in fed-batch and continuous culture of Pichia pastoris by two different methanol feeding methods. J. Biosci. Bioeng. 2007, 104:403-407.
86. Wang D.D., Su M.M., Sun Y., Huang S.L., Wang J., Yan W.Q. Expression, purification and characterization of a human single-chain Fv antibody fragment fused with the Fc of an IgG1 targeting a rabies antigen in Pichia pastoris. Protein Expr. Purif. 2012, 86:75-81.
87. Lin H., Kim T., Xiong F., Yang X. Enhancing the production of Fc fusion protein in fed-batch fermentation of Pichia pastoris by design of experiments. Biotechnol. Prog. 2007, 23:621-625.